Skip to main content
Hiroshi Yamasaki, MD, Cardiology, Roseville, MI, Ascension St. John Hospital

HiroshiYamasakiMD

Cardiology Roseville, MI

Adult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology

Eastside Cardiovascular Medicine

Dr. Yamasaki is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Yamasaki's full profile

Already have an account?

Education & Training

  • Sidney Kimmel Medical College at Thomas Jefferson University/TJUH
    Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Cardiovascular Disease, 1992 - 1995
  • New York-Presbyterian/Queens
    New York-Presbyterian/QueensResidency, Internal Medicine, 1989 - 1992
  • Faculty of Medicine Kyoto University
    Faculty of Medicine Kyoto UniversityClass of 1989

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 1996 - 2025
  • PA State Medical License
    PA State Medical License 1992 - 1996
  • American Board of Internal Medicine Cardiovascular Disease
  • American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
  • Fellow (FACP) American College of Physicians, 2003
  • Fellow (FACC) American College of Cardiology

Publications & Presentations

PubMed

Journal Articles

  • Association of Race with Long-Term Outcomes in Patients Undergoing Popliteal and Infra-Popliteal Percutaneous Peripheral Arterial Interventions  
    Hiroshi Yamasaki, Thomas Lalonde, Rajendra H Mehta, Mohammad Alasaad, Howard S Rosman, ScienceDirect

Press Mentions

  • Dominant-Negative Abrogation of Connexin-Mediated Cell Growth Control by Mutant Connexin Genes
    Dominant-Negative Abrogation of Connexin-Mediated Cell Growth Control by Mutant Connexin GenesOctober 30th, 1997
  • Aberrant Expression, Function and Localization of Connexins in Human Esophageal Carcinoma Cell Lines with Different Degrees of Tumorigenicity
    Aberrant Expression, Function and Localization of Connexins in Human Esophageal Carcinoma Cell Lines with Different Degrees of TumorigenicityAugust 15th, 1994

Professional Memberships

Hospital Affiliations